• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症的免疫疗法已臻成熟。

Immunotherapy of cancers comes of age.

机构信息

a Research Center for Immunodeficiencies, Children's Medical Center , Tehran University of Medical Sciences , Tehran , Iran.

b Department of Endodontics, Dental Branch , Tehran Azad University , Tehran , Iran.

出版信息

Expert Rev Clin Immunol. 2017 Oct;13(10):1001-1015. doi: 10.1080/1744666X.2017.1366315. Epub 2017 Aug 23.

DOI:10.1080/1744666X.2017.1366315
PMID:28795649
Abstract

Cancer immunotherapy has evolved and is aimed at generating the efficacious therapeutic modality to enhance the specificity and power of the immune system to combat tumors. Areas covered: Current efforts in cancer immunotherapy fall into three main approaches. One approach is through the blockade of immune checkpoints, another approach is through adoptive cellular therapy, and the last approach is through vaccination. The goal of this review is to summarize the current understanding and status of cancer immunotherapy in these three categories. Expert commentary: We foresee the development of therapeutic protocols combining these approaches with each other or conventional therapies to achieve the most appropriate guideline for management of cancer.

摘要

癌症免疫疗法已经发展,旨在产生有效的治疗方式,以提高免疫系统对抗肿瘤的特异性和效力。

涵盖领域

目前癌症免疫疗法的努力分为三种主要方法。一种方法是通过阻断免疫检查点,另一种方法是通过过继性细胞疗法,最后一种方法是通过疫苗接种。本综述的目的是总结这三种方法中癌症免疫疗法的当前理解和现状。

专家评论

我们预计将这些方法与常规疗法相结合或联合常规疗法开发治疗方案,以制定最适合癌症管理的指南。

相似文献

1
Immunotherapy of cancers comes of age.癌症的免疫疗法已臻成熟。
Expert Rev Clin Immunol. 2017 Oct;13(10):1001-1015. doi: 10.1080/1744666X.2017.1366315. Epub 2017 Aug 23.
2
Immunotherapy as an Option for Cancer Treatment.免疫疗法作为癌症治疗的一种选择。
Arch Immunol Ther Exp (Warsz). 2018 Apr;66(2):89-96. doi: 10.1007/s00005-017-0491-5. Epub 2017 Oct 12.
3
An overview of cancer immunotherapeutic strategies.癌症免疫治疗策略概述。
Immunotherapy. 2018 Aug;10(11):999-1010. doi: 10.2217/imt-2018-0002.
4
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.癌症免疫检查点阻断的耐药机制:肿瘤内在和外在因素。
Immunity. 2016 Jun 21;44(6):1255-69. doi: 10.1016/j.immuni.2016.06.001.
5
Checkpoint-modulating immunotherapies in tumor treatment: Targets, drugs, and mechanisms.肿瘤治疗中的检查点调节免疫疗法:靶点、药物和机制。
Int Immunopharmacol. 2019 Feb;67:160-175. doi: 10.1016/j.intimp.2018.12.006. Epub 2018 Dec 12.
6
Immunotherapies: Exploiting the Immune System for Cancer Treatment.免疫疗法:利用免疫系统治疗癌症。
J Immunol Res. 2018 Mar 14;2018:9585614. doi: 10.1155/2018/9585614. eCollection 2018.
7
The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy.基于纳米颗粒的药物传递系统在检查点阻断癌症免疫治疗中的应用。
J Immunol Res. 2018 Sep 30;2018:3673295. doi: 10.1155/2018/3673295. eCollection 2018.
8
Adoptive cell therapy: past, present and future.过继性细胞疗法:过去、现在与未来。
Immunotherapy. 2017 Jan;9(2):183-196. doi: 10.2217/imt-2016-0112.
9
Chimeric antigen receptor T cell therapy and other therapeutics for malignancies: Combination and opportunity.嵌合抗原受体 T 细胞疗法和其他恶性肿瘤治疗方法:联合与机遇。
Int Immunopharmacol. 2019 May;70:498-503. doi: 10.1016/j.intimp.2019.01.010. Epub 2019 Mar 13.
10
Autoimmune Cardiotoxicity of Cancer Immunotherapy.癌症免疫治疗的自身免疫性心脏毒性。
Trends Immunol. 2017 Feb;38(2):77-78. doi: 10.1016/j.it.2016.11.007. Epub 2016 Dec 2.

引用本文的文献

1
First-in-human evaluation of a no-alpha interleukin-2 mutein: safety and preliminary pharmacodynamic and clinical effect.无α白细胞介素-2突变体的首次人体评估:安全性、初步药效学及临床效果
Front Immunol. 2025 May 23;16:1589042. doi: 10.3389/fimmu.2025.1589042. eCollection 2025.
2
Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors.免疫疗法在小肠神经内分泌肿瘤治疗中的现状。
Curr Oncol Rep. 2024 Nov;26(11):1530-1542. doi: 10.1007/s11912-024-01610-w. Epub 2024 Oct 28.
3
Self-Assembly Study of Block Copolypeptoids in Response to pH and Temperature Stimulation.
响应pH和温度刺激的嵌段共聚多肽的自组装研究。
Polymers (Basel). 2024 Apr 12;16(8):1082. doi: 10.3390/polym16081082.
4
Effects of different KRAS mutants and Ki67 expression on diagnosis and prognosis in lung adenocarcinoma.不同KRAS突变体和Ki67表达对肺腺癌诊断及预后的影响
Sci Rep. 2024 Feb 19;14(1):4085. doi: 10.1038/s41598-023-48307-x.
5
Pancreatic cancer: genetics, disease progression, therapeutic resistance and treatment strategies.胰腺癌:遗传学、疾病进展、治疗耐药性及治疗策略
J Cancer Metastasis Treat. 2021;7. doi: 10.20517/2394-4722.2021.96. Epub 2021 Nov 5.
6
Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.创新技术在个性化癌症医学中的应用:干细胞与基因编辑工具
ACS Pharmacol Transl Sci. 2023 Nov 14;6(12):1758-1779. doi: 10.1021/acsptsci.3c00102. eCollection 2023 Dec 8.
7
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade.癌症研究中的单细胞RNA测序:发现免疫检查点阻断的新型生物标志物和治疗靶点。
Cancer Cell Int. 2023 Dec 8;23(1):313. doi: 10.1186/s12935-023-03158-4.
8
Systemic treatment for advanced pancreatic cancer.晚期胰腺癌的全身治疗。
World J Gastrointest Oncol. 2023 Oct 15;15(10):1691-1705. doi: 10.4251/wjgo.v15.i10.1691.
9
Functional characterization of TSPAN7 as a novel indicator for immunotherapy in glioma.TSPAN7 作为一种新型的胶质瘤免疫治疗标志物的功能特征。
Front Immunol. 2023 Feb 9;14:1105489. doi: 10.3389/fimmu.2023.1105489. eCollection 2023.
10
The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy.外周血细胞和淋巴细胞亚群对接受新辅助放化疗的食管鳞癌患者的预测价值。
Front Immunol. 2022 Nov 14;13:1041126. doi: 10.3389/fimmu.2022.1041126. eCollection 2022.